Dr. Rakesh Mishra, Director, Tata Institute for Genetics and Society, India speaks to The Hindu on the COVID-19 pandemic, vaccines, variants and steps we need to take in order to ensure maximum safety, without hampering the economy.
16Feb
Related Posts
22Feb
Award to Dr. Mansi Malik
Dr. Mansi Malik, Scientist at TIGS recently won the 'Best Turbo Talk... read more
01Jul
Hybrid immunity will end pandemic
Are vaccines safe? Is booster dose required? Does COVID19 vaccine affect children? In... read more
24Jul
Booster doses, Covid-appropriate behaviour key to check virus spread
Administering booster doses and following Covid-appropriate behaviour are important to not let... read more
16Dec
India must scale up wastewater analysis for health surveillance
In this latest opinion piece by Dr. Farah Ishtiaq, Principal Scientist, TIGS... read more
03Dec
Healthcare to agriculture: How genome revolution could be game changer
One of the biggest developments in science has been the precise deciphering... read more
06May
Wastewater study detects a large, silent wave in Bengaluru
The XBB.1.16 Omicron recombinant first detected in India on December 25, 2022... read more
04Sep
MoU Signing with Gujrat Biotechnology Research Centre
TIGS and Gujarat Biotechnology Research Centre (GBRC), Department of Science and Technology, Government... read more
22May
DBT – BIRAC grant to Dr. Vasanth
Dr. Vasanth Thamodaran was recently award a DBT - BIRAC grant to... read more
12Mar
कोरोना के नए वैरिएंट
टाटा इंस्टीट्यूट फॉर जेनेटिक्स एंड सोसाइटी के निदेशक राकेश मिश्रा का कहना... read more
10Oct
Bangalore Life Science Cluster condoles death of Ratan Tata
The Bangalore Life Science Cluster (BLiSc) condoled the death of Ratan N... read more